News stories about "combination" in India.

AbbVie's blood cancer combo therapy fails in late-stage study

AbbVie (ABBV.N) said on Friday a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully increase the survival rate of patients without the disease worsening. Key Points

Reuters

Moderna, Merck begin late-stage study for mRNA cancer therapy

Moderna (MRNA.O) and Merck & Co (MRK.N) said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with blockbuster drug Keytruda for patients with a type of lung cancer. Key Points

Reuters

Moderna combo COVID-19/flu vaccine succeeds in early-stage trial

Moderna (MRNA.O) on Wednesday said its combination vaccine to protect against both COVID-19 and influenza generated a strong immune response compared to individual shots for the viruses in an early-stage study. Key Points

Reuters

Pickleball is the new golf as CEOs get a taste of sport

Pickleball, a combination of tennis, ping-pong, and badminton, is gaining popularity among CEOs and their families in India, with clubs such as Bay Club at Jio World in Mumbai and Vasant Vihar Club in Delhi now having dedicated pickleball courts. The sport has also gained the endorsement of India's sports minister, Anurag Thakur, who pledged to promote it. Easy to learn and less ground to cover, pickleball is gender- and neutral, according to Srikanth Subramanian, CEO of Kotak Cherry. Key Points

Economic Times

Government bans 14 fixed-dose combination drugs, citing risk to people

The banned drugs included those used for treating common infections, cough and fever. The move comes following the recommendations by an expert committee. Key Points

India Today

Drug regulator gives conditional nod for sale of 5 FDCs, seeks efficacy & safety data for 3 of them

Popular brands using combinations under the scanner include D Cold Total and Dolo Cold. The five FDCs are part of 344 drug combinations that the government had first banned in 2016. Key Points

ThePrint

Merck's lung cancer drug combo fails to meet trial goal

Merck (MRK.N) said on Thursday its experimental therapy in combination with Keytruda to treat a type of lung cancer in previously treated patients did not meet the main goal in a mid-stage study. Key Points

Reuters

Israel-Hamas conflict, FOMC outcome to challenge gold traders' resilience this week

The US dollar saw a boost from a combination of lackluster corporate earnings, safe-haven demand, and signs of the US economy's resilience. Notably, the US economy posted robust annualized growth of 4.9% in Q3 2023, despite higher interest rates. Core PCE prices and personal spending further reinforced the notion of sustained economic strength. Key Points

Economic Times

Rolls-Royce may cut thousands of jobs in turnaround plan

Rolls-Royce Holdings Plc could cut thousands of jobs after the company hired consultants led by McKinsey & Co to advice on streamlining its operations, The Times reported. Part of the turnaround plan will see the combination of non-manufacturing departments in each of the company's civil aerospace, defence and power systems divisions, the newspaper said, citing an unidentified consultancy source. As a result, 10% of around 30,000 jobs in these departments could be eliminated, the report said. Key Points

Economic Times

Popular food combinations that can cause bloating and stomach ache

Your favourite comfort food combo could be messing with your digestion. Here are some foods that should not eaten in combination as suggested by a nutritionist. | Health Key Points

Hindustan Times

Moderna's combination skin cancer therapy receives FDA's breakthrough tag

Moderna Inc said on Wednesday its experimental personalised mRNA skin cancer vaccine in combination with Merck & Co Inc's drug Keytruda has received breakthrough therapy designation from U.S. regulators as an additional treatment for high risk patients. Key Points

Reuters